Evonik announced its third quarter and nine month results for2016   In the first nine months of this year, Evonik Group sales declined 8% year-on-year to €9,527 million. This was mainly due to lower selling prices. At the same time, volume sales rose by 2%. Adjusted EBITDA was 12% below the very high prior-year level at €1,728 million. The adjusted EBITDA margin was very good at 18.1%.   “In the third quarter of 2016 Evonik continued the volume growth seen in the first six months, despite th...